|
US2021121425A1
|
|
Electrophilic nitroalkene benzoic acid derivates as therapeutic drugs in amyotrophic lateral sclerosis (als) and other neurodegenerative conditions
|
|
WO2020222231A1
|
|
Ionic channel modulation as a method for treating tumors through inflammasome activation
|
|
US2020155486A1
|
|
Methods of Treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic Modulators
|
|
US2018318273A1
|
|
Immunoresponsive Methods of Treating Tumors
|
|
EP3732162A1
|
|
Nitroalkene non steroidal anti-inflammatory drugs (na-nsaids) and methods of treating inflammation related conditions
|
|
US2019194121A1
|
|
Nitroalkene non steroidal anti-inflammatory drugs (NA-NSAIDs) and methods of treating inflammation related conditions
|
|
US2018137236A1
|
|
System, method and device for identifying discriminant biological factors and for classifying proteomic profiles
|
|
CN110325182A
|
|
Use the anti-inflammatory method with metabolism regulators treatment inflammatory-related disorders of multipotency
|
|
US2018057475A1
|
|
Nitroalkene trolox derivatives and methods of use thereof in the treatment and prevention of inflammation related conditions
|
